FREE Participation for Pharmaceutical & Biotechnology Companies.
The recent years have witnessed major growth in the inhaled drugs market driven by rising prevalence of chronic pulmonary diseases, the evolution of inhaled therapies and technological advancements in device development. Challenges still remain to ensure safe and efficient respiratory drug delivery - including device and drug integration, particle engineering and formulation technologies, clinical studies and regulatory pathways. Our meeting facilitates hands-on experience sharing of successful development of inhaled drug products for enhanced patient care.
12:00 Registration
12:20 Opening Address from the Chairman
12:30 Understanding of regulations and requirements for OINDPs.
Andrew Feilden,
European E&L strategic Director, Hall Analytical, Shawbury, United Kingdom
13:00 Questions & Answers
13:10 Digital Health in IDD: advances in digital technologies, opportunities and associated challenges overcome.
Guilherme Safioti,
Medical Director, GMA Connected Respiratory, Teva Pharmaceuticals, Sweden
13:40 Questions & Answers
13:50 Break
14:00 To Be Announced.
Mark Milton-Edwards,
Head of Product & Health Solutions, Digital Health, Teva Pharmaceuticals, Tytherington, United Kingdom
14:30 Questions & Answers
14:40 Lung on chip applicatons in risperatory health.
Nina Hobi,
CEO & Scientific Director, AlveoliX AG, Bern, Switzerland
15:10 Questions & Answers
15:20 Break
15:30 To Be Announced
Sandro Laiso,
Business Development Manager DACH Chemicals & Pharmaceuticals, Intertek (Schweiz) AG, Basel, Switzerland
16:00 Questions & Answers
16:10 Inhaled phage therapy as an alternative to antibiotics in respiratory tract infections.
Nathalie Heuzé-Vourc’h,
Research Director, INSERM, Tours, France
16:40 Questions & Answers
16:50 Break
17:00 Cell culture models in IDD.
Dr. Carsten Ehrhardt,
Professor in Pharmaceutics and Biopharmaceutics, Trinity College Dublin, Ireland
17:30 Questions & Answers
17:40 Closing remarks and end of day one
12:00 Registration
12:20 Opening Address from the Chairman
12:30 The climate is changing for metered dose inhalers.
Dr. John N Pritchard
Independent Business Owner, Inspiring Strategies, Leicester, United Kingdom
13:00 Questions & Answers
13:10 To Be Announced
Dr. Felix Weiland,
Head of Product & Process Technology, Boehringer Ingelheim microParts GmbH, Gütersloh, Germany
13:40 Questions & Answers
13:50 Break
14:00 To Be Announced.
Alex Slowey,
Formulation Specialist, Kindeva Drug Delivery, Leicester, United Kingdom
14:30 Questions & Answers
14:40 To Be Announced.
Herbert Watchel,
Senior Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co. KG, DE, Germany
15:10 Questions & Answers
15:20 Break
15:30 From perception to action - the patient DPI product interface.
Sven Stegemann,
Professor for Patient Centric Drug Development and Manufacturing, Graz University of Technology, Graz, Austria
16:00 Questions & Answers
16:10 To Be Announced.
David Harris,
Chief Technology Officer, Cambridge Healthcare Innovations, Cambridge, United Kingdom
16:40 Questions & Answers
16:50 Break
17:00 Use of 3d printing Computational fluid dynamics and customised engineering in inhalation pre-clinical development
Dr. Simon Moore, BSc(Hons) PhD MRSC,
Global Lead of Inhalation Sciences and Engineering, Covance Laboratories, United Kingdom
17:30 Questions & Answers
17:40 Closing remarks and end of day two
To register to the summit as Delegate, Exhibitor or Sponsor, please provide the details below. Once the form is submitted, we will send you the official confirmation and the invoice for payment. In case of doubt, contact us at info@qepler.com
*Please note, all participation packages, contains complete conference materials distribution after the event (Slides, list of participants, stream and video recording). You don't need to order additional "Documentation Packages".
For SPONSORSHIP packages, please youse our PDF registration form:
Please fill in the details below to request your copy of the latest summit agenda and event details.
Documentation Package for € 495 includes complete conference materials.
Post-event presentations with video records, slide decks, list of participants and other promotional materials.
*The presentation content is subject to speaker’s companies approval for distribution.
Please fill in all the details carefully and submit your application. Should you face any problems with filling the form, please contact us at info@qepler.com
3M United Kingdom PLC - 4Pharma - Agartee Technology Inc. - AGES - Medizinmarktaufsicht LCM/QUAL - Aptar Pharma - Aptuit Srl - Boehringer Ingelheim - Boehringer Ingelheim microParts GmbH - Covestro Deutschland AG - CSL Behring - CSL Behring GmbH - Emmace Consulting AB - Ferring Pharmaceuticals - GlaxoSmithKline - Graz University of Technology - Harro Höfliger Verpackungsmaschinen GmbH - Iconovo AB - Inspiring Strategies - JSC «FARMAK» - Nanologica - Novartis - Pari - Paul Johnson Consulting Limited - Saarland University - Skyepharma AG (Vectura Group) - Smithers Rapra Ltd - Softhale NV - Trinity College Dublin - Others